Streetbeat News

Products Services

RELY

Remitly Global, Inc. (NASDAQ: RELY) will present at the 2024 Wells Fargo TMT Summit, showcasing its digital financial services.

Portfolio Pulse from

November 25, 2024 | 9:15 pm

SANA

Sana Biotechnology, Inc. (NASDAQ: SANA) will webcast presentations at two investor conferences in December 2024, featuring a business overview and update by CEO Steve Harr.

Portfolio Pulse from

November 25, 2024 | 9:15 pm

ALEC

Alector, Inc. announced that its Phase 2 trial for AL002 in early Alzheimer's patients did not meet primary or secondary endpoints, showing no significant treatment effects. The trial also observed MRI changes and infusion-related reactions.

Portfolio Pulse from

November 25, 2024 | 9:15 pm

CMPS

Compass Pathways plc (Nasdaq: CMPS) will participate in upcoming investor conferences, including the Evercore ISI HealthCONx Conference and the Piper Sandler Healthcare Conference, to discuss their innovations in mental health.

Portfolio Pulse from

November 25, 2024 | 9:15 pm

APD

Air Products' stock has reached a 52-week high due to its strategic investments in high-return industrial gas projects and efforts in productivity and cost improvements.

Portfolio Pulse from

November 25, 2024 | 9:15 pm

SMTI

Sanara MedTech Inc. (Nasdaq: SMTI) will present at the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024. The presentation will be delivered by Ron Nixon, the company's Chairman and CEO, focusing on their medical technology innovations.

Portfolio Pulse from

November 25, 2024 | 9:15 pm

CIBR

The article discusses the importance of cybersecurity in light of the 'Salt Typhoon' cyberattack and highlights the growth potential of the global cybersecurity market. It mentions the First Trust Nasdaq Cybersecurity ETF (CIBR) as a diversified fund that has outperformed the S&P500 over the past five years.

Portfolio Pulse from

November 25, 2024 | 9:00 pm

BMY

Bristol-Myers Squibb's stock is on the rise due to a Q3 2024 earnings surprise, raised 2024 guidance, and FDA approval for a new schizophrenia treatment. Despite a high P/E ratio, projections for 2025 suggest significant earnings growth, potentially doubling the stock price.

Portfolio Pulse from

November 25, 2024 | 9:00 pm

EQL

Investors are considering moving out of cash due to market volatility concerns. The Equal Weight ETF (EQL) is appealing as it mitigates concentration risk amidst potential AI bubble and inflation worries.

Portfolio Pulse from

November 25, 2024 | 9:00 pm